AGAP3

AGAP3 is a multidomain signaling scaffold in excitatory synapses that couples neurotransmitter receptor activation to intracellular signal transduction and synaptic plasticity. It resides in the NMDA receptor complex and, through its GTPase-like, pleckstrin homology, and ArfGAP domains, links NMDA receptor activation to Ras/ERK and Arf6 signaling, thereby controlling AMPA receptor trafficking to synapses during long-term potentiation (PMID:23904596). Its short splice variant CRAG possesses intrinsic GTPase activity, interacts with ELK1 at PML bodies to activate SRF-dependent c-Fos transcription, and is required for hippocampal granule cell maturation, as forebrain-specific knockout mice display arrested dentate gyrus neuron maturation and hyperactivity (PMID:31882856, PMID:33811862). AGAP3-BRAF gene fusions, in which AGAP3 replaces the auto-inhibitory N-terminus of BRAF, constitutively activate MAPK signaling and confer resistance to BRAF inhibitors while retaining sensitivity to MEK inhibitors in melanoma and colorectal cancer models (PMID:28539463, PMID:31911540).

1. 2011 High

   Establishing that the CRAG splice variant couples nuclear ubiquitin-proteasome function to SRF/c-Fos transcriptional activation answered how AGAP3 isoforms participate in nuclear signaling, revealing a nuclear localization signal and domain requirements for SRF activation.

   Evidence Mutagenesis, siRNA knockdown, dominant-negative expression, and SRF/AP-1 reporter assays in cultured cells

   PMID:21832068

   Open questions at the time

   • Direct nuclear substrates of CRAG's ArfGAP or GTPase domains were not identified
   • In vivo physiological relevance of polyQ-triggered CRAG activity not yet demonstrated
2. 2013 High

   Identification of AGAP3 as an NMDA receptor complex component that bridges NMDA receptor activation to Ras/ERK and Arf6 pathways answered how synaptic activity drives AMPA receptor insertion during LTP.

   Evidence Co-immunoprecipitation with NMDA receptor complex, shRNA knockdown in rat primary neurons with chemical LTP induction and AMPA receptor trafficking assays

   PMID:23904596

   Open questions at the time

   • Whether AGAP3's ArfGAP catalytic activity is required for LTP trafficking was not tested
   • Specific Arf6 substrates or effectors downstream of AGAP3 in LTP remain unidentified
3. 2017 Medium

   Demonstration that AGAP3-BRAF fusions activate MAPK signaling and confer BRAF inhibitor resistance while preserving MEK inhibitor sensitivity established how AGAP3 genomic rearrangements contribute to oncogenic bypass signaling.

   Evidence Expression of AGAP3-BRAF fusion in BRAFV600E melanoma cells with drug sensitivity assays; parallel characterization in patient-derived colorectal cancer organoids

   PMID:28539463 PMID:31911540

   Open questions at the time

   • Whether the AGAP3 portion contributes signaling or merely membrane localization to the fusion is incompletely resolved
   • In vivo tumorigenic potential of the AGAP3-BRAF fusion not tested in animal models
4. 2019 High

   Demonstrating that CRAG possesses intrinsic GTPase activity and activates SRF via ELK1 at PML bodies through SUMO-interacting motifs resolved the enzymatic basis and subnuclear site of CRAG-mediated transcriptional activation; knockout mice confirmed in vivo relevance for c-fos induction.

   Evidence GTPase activity assay, Co-IP of CRAG-ELK1, SUMO-interacting motif mutagenesis, centaurin-γ3 knockout mice with kainic acid stimulation

   PMID:31882856

   Open questions at the time

   • GTP hydrolysis rate constants and nucleotide specificity not quantitatively determined
   • Whether GTPase and ArfGAP activities are independently regulated is unknown
5. 2019 Medium

   Identification of AGAP3 as an insulin-responsive phosphoprotein within the CLASP2/CLIP2 microtubule plus-end tracking network in adipocytes expanded AGAP3 function beyond neurons to metabolic signaling.

   Evidence Affinity purification–mass spectrometry and targeted quantitative phosphoproteomics in 3T3-L1 adipocytes after insulin stimulation

   PMID:28550165 PMID:31539989

   Open questions at the time

   • Functional consequence of AGAP3 phosphorylation on microtubule dynamics or GLUT4 trafficking not tested
   • Whether AGAP3 ArfGAP activity is relevant in adipocytes is unknown
6. 2021 High

   Forebrain-specific CRAG knockout causing hippocampal granule cell maturation arrest and hyperactivity established AGAP3/CRAG as essential for postnatal neuronal maturation in vivo.

   Evidence Conditional knockout mice, doublecortin/calbindin immunohistochemistry, open-field behavioral testing

   PMID:33811862

   Open questions at the time

   • Downstream transcriptional targets mediating maturation are not identified
   • Whether the maturation defect arises from impaired SRF/c-Fos signaling or AMPA receptor trafficking is unresolved

• It remains unknown how AGAP3's GTPase, PH, and ArfGAP domains are coordinately regulated, whether its ArfGAP catalytic activity is required for synaptic plasticity, and what distinguishes the functional roles of full-length AGAP3 versus the CRAG splice variant in different cellular contexts.
• No structural model of AGAP3 exists
• Domain-specific catalytic contributions to LTP versus transcription are not separated
• Isoform-specific interactomes have not been systematically compared